RYTM: Rhythm Pharmaceuticals, Inc. Stock

by  •  • Comments Off on RYTM: Rhythm Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,514.73
Enterprise Value ($M) 3,717.93
Book Value ($M) 152.70
Book Value / Share 2.48
Price / Book 23.02
NCAV ($M) 129.47
NCAV / Share 2.11
Price / NCAV 27.15

Profitability (mra)
Return on Invested Capital (ROIC) -0.97
Return on Assets (ROA) -0.78
Return on Equity (ROE) -1.53

Liquidity (mrq)
Quick Ratio 3.34
Current Ratio 3.49

Balance Sheet (mrq) ($M)
Current Assets 340.34
Assets 363.57
Liabilities 210.88
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G Perceptive Advisors Llc 8.60 5.67
11-14 13G/A Ra Capital Management, L.p. 9.95 14.15
11-12 13G/A Goldman Sachs Group Inc 6.40 -22.16
11-12 13G/A Primecap Management Co/ca/ 11.81 -10.38
04-30 13D/A New Enterprise Associates 13 Lp
02-14 13G/A Baker Bros. Advisors Lp 10.80 0.69
02-13 13G Vanguard Group Inc 5.46
2024-01-24 13G/A BlackRock, Inc. 10.70 1.38
2024-01-23 13G/A State Street Corp 3.73 -30.64

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-29 10-K ‘ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 95,557 321,427 29.73
2025-01-30 39,823 249,580 15.96
2025-01-29 27,627 229,203 12.05
2025-01-28 26,996 373,140 7.23
2025-01-27 38,079 276,959 13.75

(click for more detail)

Similar Companies
RNA – Avidity Biosciences, Inc. RNAC – Cartesian Therapeutics, Inc.
RVNC – Revance Therapeutics, Inc. SAGE – Sage Therapeutics, Inc.
SCYX – SCYNEXIS, Inc.


Financial data and stock pages provided by
Fintel.io